2011 in Review: A Year of Innovation, Record Net Cash and The Cultivation of Enterprise 3.0
As 2011 comes to a close, it offers us an opportunity to look back at the major milestones and key events of the year. While…
Posted by
Safeguard Insights
Recap: Safeguard Scientifics Investor Day 2011
Earlier this week we held our Fifth Annual Investor Day 2011 where investors and analysts heard presentations from Safeguard executives and highlighted partner companies on…
Posted by
Safeguard Scientifics Investor Day 2011 is 4 Days Away. RSVP Now!
Safeguard Scientifics Investor Day 2011 is right around the corner. Join executives from Safeguard Scientifics and select partner companies at The Yale Club of New York…
Posted by
Safeguard Scientifics Announces Details for Investor Day 2011
This morning, we announced that planning is underway for Safeguard Scientifics Investor Day 2011. Join us at The Yale Club of New York City on…
Posted by
Communicating Value and Increasing Transparency: Medical Devices
Changing The Standard of Care New medical devices, born of the convergence of healthcare and technology, represent a promising growth opportunity for Safeguard Scientifics. Our…
Posted by
Communicating Value and Increasing Transparency: Internet / New Media
There is no question that our lives today revolve around the Internet. Our daily interactions with the web and related new media are growing rapidly.…
Posted by
Safeguard Scientifics Fourth Quarter and Year-End Financial Results Recap, Highlighting Aggregate Partner Company Revenue Growth, Acquisitions and IPOs
This morning, we announced our fourth quarter and year-end 2010 financial results. In 2010, our aggregate partner company revenue was $403 million, up 54 percent…
Posted by
Social Media IPOs—A Trend to Alter VC Investment?
I was reading an article by the San Jose Mercury News’ Patrick May recently, titled “IPOs by LinkedIn, Facebook, Twitter and others could alter venture…
Posted by
Safeguard Scientifics Aggregate Partner Company Revenue Exceeds $400 Million in 2010
Safeguard Scientifics’ value creation strategy is to deploy capital and build value in our partner companies. One of the best ways to evaluate our progress is…
Posted by
